Tamara Strauss, the first patient to enroll in a first-of-its-kind clinical trial at Moores Cancer Center at UC San Diego Health to test a personalized vaccine using her unique cancer mutations to boost an anti-tumor immune response, joins Ezra Cohen, MD, associate director for translational science at Moores Cancer Center, and Stephen Schoenberger, PhD, professor of immunology at the La Jolla Institute for Allergy & Immunology, to talk about hope for a new personalized cancer vaccine. Drs. Cohen and Schoenberger developed a new technology that identifies a patient’s unique targets that can be used to create a vaccine specific to each individual person. The pilot study is enrolling 10 patients with solid tumors as a first step. To learn more about this research visit cancer.ucsd.edu.